About: Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.   Goto Sponge  NotDistinct  Permalink

An Entity of Type : owl:Thing, within Data Space : data.idref.fr associated with source document(s)

AttributesValues
Author
Bibliographic Citation
  • Chua Ming Jang, Arnold Megan S J, Xu Weijun, Lancelot Julien, Lamotte Suzanne, Späth Gerald F, Prina Eric, Pierce Raymond J, Fairlie David P, Skinner-Adams Tina S. Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.. International journal for parasitology. Drugs and drug resistance, 2017, 7 (1), pp.42-50. ⟨10.1016/j.ijpddr.2016.12.005⟩
Title
  • Effect of clinically approved HDAC inhibitors on Plasmodium, Leishmania and Schistosoma parasite growth.
dc:date
  • 2017
Digital Object Identifier (DOI)
  • 10.1016/j.ijpddr.2016.12.005
Faceted Search & Find service v1.13.91 as of Aug 16 2018


Alternative Linked Data Documents: ODE     Content Formats:       RDF       ODATA       Microdata      About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data]
OpenLink Virtuoso version 07.20.3229 as of May 14 2019, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (70 GB total memory)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2025 OpenLink Software